Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Papillomavirus Infections

quinazolines has been researched along with Papillomavirus Infections in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, JH; Li, MF; Shiau, EL; Wu, MT1
Biddinger, P; Dillard, T; Hao, Z; Patel, V1
Arora, H; Biswas, S; Gandhi, G; Naseem, A; Perwez, A; Qureshi, R; Rizvi, MA; Wajid, S1
Aikou, T; Akiba, S; Baba, M; Castillo, A; Eizuru, Y; Higashi, M; Itoh, T; Khan, N; Koriyama, C; Matsumoto, H; Natsugoe, S; Shuyama, KY; Yanagi, M1
Diefendorf, LP; Jette, DF; Mohammed, A; Mondal, S; Moses, MA; Searleman, SA; Stevens, DA; Wilton, KM; Woodworth, CD1
Gasol-Cudós, A; Llombart-Cussac, A; Márquez-Medina, D; Salud-Salvia, A; Samamé Pérez-Vargas, JC; Taberner-Bonastre, MT1
Bostrom, B; Drehner, D; Lander, T; Marker, S; Sidman, J1
Bassuk, JA; Carmean, N; Hudson, AE; Kosman, JW; Leaf, EM; Opheim, KE1

Other Studies

8 other study(ies) available for quinazolines and Papillomavirus Infections

ArticleYear
Recurrent respiratory papillomatosis with lung involvement and malignant transformation.
    Thorax, 2014, Volume: 69, Issue:3

    Topics: Bronchial Neoplasms; Bronchoscopy; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chemoradiotherapy, Adjuvant; Contrast Media; Disease Progression; Erlotinib Hydrochloride; Humans; Male; Middle Aged; Papillomavirus Infections; Protein Kinase Inhibitors; Quinazolines; Respiratory Tract Infections; Tomography, X-Ray Computed; Treatment Outcome

2014
Suppression of respiratory papillomatosis with malignant transformation by erlotinib in a kidney transplant recipient.
    BMJ case reports, 2013, Aug-28, Volume: 2013

    Topics: Bronchoscopy; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Erlotinib Hydrochloride; Humans; Kidney Transplantation; Lung Neoplasms; Male; Middle Aged; Papillomavirus Infections; Protein Kinase Inhibitors; Quinazolines; Respiratory Tract Infections; Thoracic Surgery, Video-Assisted

2013
Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents; Cell Line, Tumor; DNA Mutational Analysis; ErbB Receptors; Exons; Female; Gefitinib; HeLa Cells; Human papillomavirus 16; Human papillomavirus 18; Humans; India; Middle Aged; Mutation; Papillomavirus Infections; Protein Kinase Inhibitors; Quinazolines; Uterine Cervical Neoplasms

2016
Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas.
    Oncology reports, 2010, Volume: 23, Issue:4

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Female; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Prevalence; Quinazolines; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53

2010
Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
    Virology, 2011, Dec-05, Volume: 421, Issue:1

    Topics: Apoptosis; Cell Transformation, Viral; Cervix Uteri; Down-Regulation; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Viral; Human papillomavirus 16; Humans; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Protein Kinase Inhibitors; Quinazolines; Repressor Proteins; Signal Transduction; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2011
Human papillomavirus in non-small-cell lung cancer: the impact of EGFR mutations and the response to erlotinib.
    Archivos de bronconeumologia, 2013, Volume: 49, Issue:2

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; ErbB Receptors; Erlotinib Hydrochloride; Female; Genes, erbB-1; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Proteins; Papillomavirus Infections; Prevalence; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Smoking; Spain

2013
Gefitinib therapy for life-threatening laryngeal papillomatosis.
    Archives of otolaryngology--head & neck surgery, 2005, Volume: 131, Issue:1

    Topics: Adolescent; Antiviral Agents; Bronchoscopy; ErbB Receptors; Gefitinib; Humans; Laryngeal Neoplasms; Male; Papilloma; Papillomavirus Infections; Protein Kinase Inhibitors; Quinazolines; Recurrence; Treatment Outcome

2005
Immortalization of human urothelial cells by human papillomavirus type 16 E6 and E7 genes in a defined serum-free system.
    Cell proliferation, 2007, Volume: 40, Issue:2

    Topics: Animals; Cell Cycle; Cell Growth Processes; Cell Line, Transformed; Cell Transformation, Viral; Cells, Cultured; Clone Cells; Culture Media, Serum-Free; Epidermal Growth Factor; ErbB Receptors; Genes, Viral; Human papillomavirus 16; Humans; Karyotyping; Keratins; Mice; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Phenotype; Quinazolines; Repressor Proteins; Telomerase; Urothelium

2007